Page last updated: 2024-11-05

thiomuscimol and Amyotrophic Lateral Sclerosis

thiomuscimol has been researched along with Amyotrophic Lateral Sclerosis in 1 studies

thiomuscimol: used as GABA analog; structure

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jaronen, M1
Vehviläinen, P1
Malm, T1
Keksa-Goldsteine, V1
Pollari, E1
Valonen, P1
Koistinaho, J1
Goldsteins, G1

Other Studies

1 other study available for thiomuscimol and Amyotrophic Lateral Sclerosis

ArticleYear
Protein disulfide isomerase in ALS mouse glia links protein misfolding with NADPH oxidase-catalyzed superoxide production.
    Human molecular genetics, 2013, Feb-15, Volume: 22, Issue:4

    Topics: Amyotrophic Lateral Sclerosis; Animals; Anterior Horn Cells; Astrocytes; Cell Line; Enzyme Activatio

2013